Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Revenue

Amylyx Pharmaceuticals had revenue of $-1.02M in the quarter ending June 30, 2024, a decrease of -101.04%. This brings the company's revenue in the last twelve months to $298.76M, up 55.71% year-over-year. In the year 2023, Amylyx Pharmaceuticals had annual revenue of $380.79M with 1,612.94% growth.

• Revenue (ttm): $298.76M
• Revenue Growth: +55.71%
• P/S Ratio: 1.15
• Revenue / Employee: $778,026
• Employees: 384
• Market Cap: 345.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	380.79M	358.56M	1,612.94%
Dec 31, 2022	22.23M	21.95M	7,700.00%
Dec 31, 2021	285.00K	-365.00K	-56.15%
Dec 31, 2020	650.00K	-776.00K	-54.42%
Dec 31, 2019	1.43M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.